Our findings indicated a significant upregulation of fibrotic markers, specifically fibronectin and α-SMA, in the lung tissues of IPF patients, accompanied by a marked 2.48-fold increase in SIK2 protein levels (p < 0.05) (Figure 1A). This evidence concerns the gene ACTA1 and idiopathic pulmonary fibrosis.